Michael Halstead, EVP and General Counsel: Intra-Cellular Therapies ITCI Sell · Filed 23/02/22

Trade details

Type: Insider sale
Amount: $432,821.76
Shares · price: 9,296 sh · $46.56 a share
Held after: 1,843 sh
Stock: Intra-Cellular Therapies ITCI
Person: Michael HalsteadEVP and General Counsel
Trade date: 23/02/21
Filed: 23/02/22
Days to filing: 1 days

Sold 83.5% of holdings

Share of holding sold: 83.5%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/01/22~23/03/23

Michael Halstead's recent trades

Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$1.3M
15,105 sh
$1.3M
Filed 24/11/14
Traded 24/11/12
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$1.2M
13,371 sh
$1.2M
Filed 24/11/14
Traded 24/11/13
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$548.2K
6,116 sh
$548.2K
Filed 24/11/14
Traded 24/11/12
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$475.1K
5,343 sh
$475.1K
Filed 24/11/14
Traded 24/11/13
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$149.8K
1,648 sh
$149.8K
Filed 24/11/14
Traded 24/11/12